Events List

KDIGO Announce publication of the Nomenclature for kidney function and Disease

Key Take-Home Points 1- Use ‘kidney’ rather than ‘renal’ or ‘nephro’ when referring to kidney disease and kidney function 2- Use ‘kidney failure’ with appropriate descriptions of presence or absence of symptoms, signs, and treatment (rather than ‘end-stage’ disease since latter term is not patient-sensitive and connotes stigma) 3- Use the KDIGO definition and classification of acute kidney diseases and disorders (AKD) and acute kidney injury (AKI) (rather than alternative descriptions to define and classify severity of AKD and AKI; AKI stages (1, 2, 3) should be used to denote severity of AKI) 4- Use the KDIGO definition and classification of CKD rather than alternative descriptions to define and classify CKD (Ascertainment of CKD when GFR > 60 ml/min/1.73 m2 requires assessment for markers of kidney damage e.g., albuminuria. CKD should be classified according to cause and categories of GFR and albuminuria (CGA); severity of CKD should correspond to risk categories) 5- Use specific kidney measures such as albuminuria or decreased GFR to describe Alterations in kidney structure and function, respectively (rather than general descriptors such as ‘abnormal’ or ‘reduced’ kidney function) 6- Do not equate albuminuria or proteinuria as ‘decreased kidney function’ since they are markers of

EMAN Nephrology Club Meeting COVID 19 Experience in UAE Nephrology Community

1st Virtual meeting for EMAN 19 June 2020

Event Differed due to COVID 19

01 Nov 2020 1:00 AM - 31 Dec 2020 1:00 AM

This is about the event

2nd ISN Global Kidney Health Summit held in Sharjah, United Arab Emirates, in March 2018

16 Mar 2018 12:00 PM - 19 Mar 2018 12:00 PM

This manuscript emerged as an individual product of the International Society of Nephrology’s 2nd Global Kidney Health Summit held in Sharjah, United Arab Emirates, in March 2018, and portions of the material in this document have been published in the full report from the summit (Harris et al.12) . Kidney International Supplements (2020) 1 event attended by 91 global leaders from 41 countries including 16 from LMIC to develop strategy to adress the unmet needs of patients with end stage kidney disease around the world.